Ranitidine
Product Images NDC 10544-056

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ranitidine (NDC 10544-056). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

150mg 20ct (Label Ranitidine Tabss 150mg Bpi(10544 056 20) Amneal(53746 253 05) Rev0)

150mg 20ct (Label Ranitidine Tabss 150mg Bpi(10544 056 20) Amneal(53746 253 05) Rev0)
This is a product description of Ranitidine Tablets, USP 150mg. It includes the NDC, Lot number, and Expiration date. It also mentions the manufacturer and provides instructions on proper storage and usage. The tablets are repackaged by Blenheim Pharmacal Inc. and protected from light. The product is for prescription use only and should be stored at room temperature.*
FDA Label Image

Structure (Ranitidine Tablets Usp 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.